99 related articles for article (PubMed ID: 11795833)
1. Pseudomesotheliomatous adenocarcinoma of the lung with rhabdoid features.
Attems JH; Lintner F
Pathol Res Pract; 2001; 197(12):841-6. PubMed ID: 11795833
[TBL] [Abstract][Full Text] [Related]
2. Pseudomesotheliomatous carcinoma of the lung with a distinct morphology, immunohistochemistry, and comparative genomic hybridization profile.
Pardo J; Torres W; Martinez-Peñuela A; Panizo A; de Alava E; García JL
Ann Diagn Pathol; 2007 Aug; 11(4):241-51. PubMed ID: 17630107
[TBL] [Abstract][Full Text] [Related]
3. [A comparative evaluation of immunohistochemical markers for the differential diagnosis between malignant mesothelioma, non-small cell carcinoma involving the pleura, and benign reactive mesothelial cell proliferation].
Szczepulska-Wójcik E; Langfort R; Roszkowski-Sliz K
Pneumonol Alergol Pol; 2007; 75(1):57-69. PubMed ID: 17541913
[TBL] [Abstract][Full Text] [Related]
4. Calretinin, thrombomodulin, CEA, and CD15: a useful combination of immunohistochemical markers for differentiating pleural epithelial mesothelioma from peripheral pulmonary adenocarcinoma.
Comin CE; Novelli L; Boddi V; Paglierani M; Dini S
Hum Pathol; 2001 May; 32(5):529-36. PubMed ID: 11381372
[TBL] [Abstract][Full Text] [Related]
5. Case reports of primary pulmonary adenocarcinoma with pleural spread: so-called pseudomesotheliomatous adenocarcinoma.
Saito R; Kasajima A; Taniuchi S; Fujishima F; Ishida K; Nakamura Y; Yamanda S; Takahashi T; Hitomi H; Murakami K; Watanabe M; Sasano H
Pathol Int; 2012 Oct; 62(10):709-15. PubMed ID: 23005599
[TBL] [Abstract][Full Text] [Related]
6. The immunohistochemical diagnosis of mesothelioma: a comparative study of epithelioid mesothelioma and lung adenocarcinoma.
Ordóñez NG
Am J Surg Pathol; 2003 Aug; 27(8):1031-51. PubMed ID: 12883236
[TBL] [Abstract][Full Text] [Related]
7. Carcinoma of lung with rhabdoid features.
Tamboli P; Toprani TH; Amin MB; Ro JS; Ordóñez NG; Ayala AG; Ro JY
Hum Pathol; 2004 Jan; 35(1):8-13. PubMed ID: 14745719
[TBL] [Abstract][Full Text] [Related]
8. [Pseudomesotheliomatous carcinoma of the lung].
Maeda R; Isowa N; Kawasaki Y; Tokuyasu H; Itakura A; Miura H; Onuma H
Kyobu Geka; 2007 Jul; 60(7):555-8. PubMed ID: 17642217
[TBL] [Abstract][Full Text] [Related]
9. Chromosome 22q dosage in composite extrarenal rhabdoid tumors: clonal evolution or a phenotypic mimic?
Fuller CE; Pfeifer J; Humphrey P; Bruch LA; Dehner LP; Perry A
Hum Pathol; 2001 Oct; 32(10):1102-8. PubMed ID: 11679945
[TBL] [Abstract][Full Text] [Related]
10. [Rhabdoid tumor of the kidney arising in a newborn infant: description of a case with ultrastructural observations].
Terlizzo M; Ambu R; Crisponi G; Marras A; Faa G
Pathologica; 1999 Jun; 91(3):198-202. PubMed ID: 10536466
[TBL] [Abstract][Full Text] [Related]
11. Combined large cell neuroendocrine, small cell and squamous carcinomas of the lung with rhabdoid cells.
Chetty R
Pathology; 2000 Aug; 32(3):209-12. PubMed ID: 10968398
[TBL] [Abstract][Full Text] [Related]
12. Metachronus malignant rhabdoid tumor of the ileum and adenocarcinoma of lung: a unique case report.
Sheikh SS; Al-Khatti AA; Amr SS
Ann Diagn Pathol; 2008 Feb; 12(1):57-61. PubMed ID: 18164418
[TBL] [Abstract][Full Text] [Related]
13. [Clinical comparison of diffuse malignant mesothelioma of the pleura and pseudomesotheliomatous carcinoma of the lung for each case].
Yuasa H; Tomoyasu M
Kyobu Geka; 1999 Sep; 52(10):836-9. PubMed ID: 10478545
[TBL] [Abstract][Full Text] [Related]
14. Cytological differential diagnosis among adenocarcinoma, epithelial mesothelioma, and reactive mesothelial cells in serous effusions by immunocytochemistry.
Su XY; Li GD; Liu WP; Xie B; Jiang YH
Diagn Cytopathol; 2011 Dec; 39(12):900-8. PubMed ID: 20836004
[TBL] [Abstract][Full Text] [Related]
15. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions.
Friedman MT; Gentile P; Tarectecan A; Fuchs A
Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609
[TBL] [Abstract][Full Text] [Related]
16. Rhabdoid tumour of the lung is a dedifferentiated phenotype of pulmonary adenocarcinoma.
Miyagi J; Tsuhako K; Kinjo T; Iwamasa T; Hashimoto H; Ishikawa S
Histopathology; 2000 Jul; 37(1):37-44. PubMed ID: 10931217
[TBL] [Abstract][Full Text] [Related]
17. Value of calretinin immunostaining in differentiating epithelial mesothelioma from lung adenocarcinoma.
Ordóñez NG
Mod Pathol; 1998 Oct; 11(10):929-33. PubMed ID: 9796717
[TBL] [Abstract][Full Text] [Related]
18. [Pleuropulmonary tumors. Presentation of 2 cases with peculiar clinicopathologic traits].
Esquius Soriguera J; Alejo Sánchez M; Padilla Navas I; Rodríguez Casquero C; León González C
Rev Clin Esp; 1989 Oct; 185(6):303-5. PubMed ID: 2623239
[TBL] [Abstract][Full Text] [Related]
19. Malignant mixed epithelial and stromal tumor of the kidney with rhabdoid features: report of a case including immunohistochemical, molecular genetic studies and comparison to morphologically similar renal tumors.
Sukov WR; Cheville JC; Lager DJ; Lewin JR; Sebo TJ; Lewin M
Hum Pathol; 2007 Sep; 38(9):1432-7. PubMed ID: 17707262
[TBL] [Abstract][Full Text] [Related]
20. Coalescent pleural malignant mesothelioma and adenocarcinoma of the lung, involving only minor asbestos exposure.
Tsuzuki T; Ninomiya H; Natori Y; Ishikawa Y
Pathol Int; 2008 Jul; 58(7):451-5. PubMed ID: 18577116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
